PI
DYN icon

Putnam Investments’s Dyne Therapeutics DYN Stock Holding History

Putnam Investments’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$526K Buy
39,536
+2,799
+8% +$27.3K ﹤0.01% 924
2023
Q3 		$329K Sell
36,737
-313
-0.8% -$3.37K ﹤0.01% 1052
2023
Q2 		$417K Sell
37,050
-1,152
-3% -$13.6K ﹤0.01% 968
2023
Q1 		$440K Sell
38,202
-1,616
-4% -$21K ﹤0.01% 966
2022
Q4 		$461K Buy
+39,818
New +$461K ﹤0.01% 948

Other funds holding DYN

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return

Putnam Investments's DYN Position: Q4 2023 in Review

Putnam Investments increased its Dyne Therapeutics (DYN) stake by 7.6% in Q4 2023, buying an estimated $27.3K and bringing the position to 39,536 shares worth $526K. The position accounts for ﹤0.01% of the portfolio, ranked #924.

Putnam Investments first reported a position in DYN in Q4 2022 and has held it in 5 quarters since. 124 funds tracked by Wall St. Rank hold DYN as of Q4 2023.

  • Putnam Investments held 39,536 shares of Dyne Therapeutics worth $526K as of Q4 2023.
  • Putnam Investments bought 2,799 Dyne Therapeutics shares in Q4 2023, an estimated $27.3K.
  • Dyne Therapeutics made up ﹤0.01% of Putnam Investments's portfolio in Q4 2023, its #924 holding.
  • Putnam Investments first reported a position in Dyne Therapeutics in Q4 2022 and has held it in 5 quarters since.
  • 124 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q4 2023.

Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.